Pediatric Allergic Rhinitis: When Meds Fall Short
Prospective cohort compares surgical vs medical management in refractory pediatric disease.
By
Kathryn Wighton
April 9, 2026
1
Inferior turbinate reduction significantly improves sinonasal symptoms and quality of life in pediatric patients with refractory allergic rhinitis.
2
A study involving 34 patients showed greater symptom score reductions in those who underwent surgery compared to those receiving medical therapy.
3
At 1 month, 88% of surgical patients experienced complete disease regression, compared to 29% in the medical therapy group.
4
Surgical patients reported reduced reliance on intranasal corticosteroids and oral antihistamines during follow-up.
5
The study had limitations, including a small sample size and potential selection bias due to non-randomized group allocation.